What is censoring?

Statistical Primers

Censoring refers to a situation in survival analysis where the event of interest is not observed for some of the individuals under study.

In this Statistical Primer, we’ll define three types of censoring often seen in survival analysis studies.

Censoring occurs when the information on the survival time is incomplete or only partially observed.

Censoring can have a significant impact on the analysis and interpretation of survival data. It is essential to appropriately handle censoring in survival analysis to obtain accurate estimates of survival times, covariate effects, and other related parameters.

There are different types of censoring in survival analysis:

Right-censoring: This occurs when a participant is still alive or event-free at the end of the study period. In other words, the follow-up time for the participant ends before the event occurs. This is the most common type of censoring in survival analysis.
Left-censoring: This occurs when the true event time is known to be less than a certain time, but the exact time is unknown. For example, if an individual is diagnosed with a disease before the study begins but the date of onset of the disease is not known, we have left-censoring.
Interval-censoring: This occurs when the event time is known to fall within a certain interval, but the exact time of the event is unknown. For example, if a person develops glaucoma in between visits to the optician but the exact onset is unknown, we have interval censoring.

Want to learn more?

Latest Resources

Specialist subjects

Real-World Evidence (RWE)

Real-World Evidence Real-world evidence (RWE) refers to data and information that, unlike data generated in clinical trials conducted in controlled environments, has been obtained from everyday clinical practice, patient registers, or other sources outside the clinical trial setting. RWE plays a crucial role in complementing traditional clinical trial data, providing insights into the safety, effectiveness, […]

Tutorials

Multivariate joint longitudinal-survival models

Joint longitudinal-survival models have been widely developed, but there are many avenues of research where they are lacking in terms of methodological development, and importantly, accessible implementations. We think merlin fills a few gaps. In this post, we’ll take a look at the extension to modelling multiple continuous longitudinal outcomes, jointly with survival. For simplicity, I’ll concentrate […]

Statistical Primers

Censoring refers to a situation in survival analysis where the event of interest is not observed for some of the individuals under study. In this Statistical Primer, we’ll define three types of censoring often seen in survival analysis studies. Censoring occurs when the information on the survival time is incomplete or only partially observed. Censoring […]

Videos

Introduction to Epidemiological Study Designs

This video offers a comprehensive introduction to epidemiological study designs, emphasising their classification, key definitions, strengths, limitations, and practical applications. We will dive into the most commonly used study designs, exploring their structure, purpose, and the contexts in which they are most effective. Throughout the video, real-world case studies of landmark research will be used […]

Tutorials

Survival analysis with interval censoring

Interval censoring occurs when we don’t know the exact time an event occurred, only that it occurred within a particular time interval. Such data is common in ophthalmology and dentistry, where events are only picked up at scheduled appointments, but they actually occurred at some point since the previous visit. Arguably, we could say all survival data […]

Tutorials

A user-defined/custom hazard model

This tutorial will illustrate some of the more advanced capabilities of merlin when modelling survival data, but with the aim of using an accessible example. During my PhD, Paul Lambert and I developed stgenreg in Stata for modelling survival data with a general user-specified hazard function, with the generality achieved by using numerical integration to calculate the cumulative hazard […]

Specialist subjects

Methods Development

Methods Development We provide expert guidance in finding the appropriate statistical approach to answer your question… and if there isn’t yet a method, well, we can develop one. While applying biostatistics to address your research question is essential, there may be times when existing methods fall short for your specific problem. In such cases, we’re […]

Tutorials

multistate v4.4.0: semi-parametric multi-state modelling

The headlines: predictms now supports the Cox model as a transition model, estimated using merlin or stmerlin Predictions from a multi-state Cox model are implemented using a simulation approach Supported predictions from a multi-state Cox model include transition probabilities, probability, and length of stay, los Let’s take a look at what we can now do with multistate and in particular, the predictms command. We’ll […]

Tutorials

Defining a transition matrix for multi-state modelling

In this post we’ll take a look at how to define a custom transition matrix for use with our multistate package in Stata. The transition matrix A transition matrix governs the movement of a process between possible states. Within multi-state survival analysis, and particularly, the implementation of multi-state models in Stata, the transition matrix contains the most […]

Tutorials

Joint longitudinal-survival models with time-dependent effects (non-proportional hazards)

In this post we’ll focus on how to model time-dependent effects (non-proportional hazards), specifically within a joint longitudinal-survival model. Now joint models are becoming commonplace in medical research, but as always, the fundamentals still matter, and indeed are often ignored. We’re going to look at how to account for time-dependency in both baseline covariates in […]

Videos

State-of-the-art statistical models for modern HTA

At @RedDoorAnalytics, we develop methodology and software for efficient modelling of biomarkers, measured repeatedly over time, jointly with survival outcomes, which are being increasingly used in cancer settings. We have also developed methods and software for general non-Markov multi-state survival analysis, allowing for the development of more plausible natural history models, where patient history can […]

Tutorials

Probabilistic sensitivity analysis and survival models

Today we’re going to take a little look into probabilistic sensitivity analysis (PSA), and how it can be implemented within the context of survival analysis. Now PSA is used extensively in health economic modelling, where a particular parameter (or parameters) of interest, are altered or varied, to represent different scenarios and levels of variation. We […]

All Resources